TNK2 and Familial prostate cancer: In addition, Ack1 has also been shown to be critical for the progression of prostate cancer to the hormone therapy-insensitive stage, termed castration-resistant prostate cancer (CRPC) due to its ability to regulate the expression and function of androgen (AR) in an AR-independent manner [36, 37].